Dysmicrobism, inflammatory bowel disease and thyroiditis: Analysis of the literature

Journal of Biological Regulators and Homeostatic Agents

Volumn 29, Issue 2, 2015, Pages 1-8

  Tomasello, G ^a,b   Tralongo, P ^a   Amoroso, F ^a   Damiani, P ^c   Sinagra, E ^b,d   Noto, M ^a   Arculeo, V M ^a   Zein, R Jurjus ^e   Saad, W ^f   Jurjus, A ^f   Gerbino, A ^g   Leone, A ^g  

^a UNIVERSITY OF PALERMO   (Italy)

^b Euro Mediterranean Institute of Science and Technology   (Italy)

^c University of Palenno   (Italy)

^d Fondazione Istituto S Raffaeleg Giglio   (Italy)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

^f AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^g Department of Medicine   (Italy)

Author keywords

Crohn's disease; Dysbiosis; Extra intestinal manifestations of IBD; Gut microflora; IBD; Microbiota; Thyroiditis; Ulcerative colitis

Indexed keywords

PROBIOTIC AGENT;

AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CROHN DISEASE; DISEASE ASSOCIATION; HASHIMOTO DISEASE; HOST; HUMAN; IMMUNE RESPONSE; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; INTESTINE MUCOSA; NONHUMAN; REVIEW; RISK FACTOR; THYROIDITIS; ULCERATIVE COLITIS; ANIMAL; BACTERIAL TRANSLOCATION; FERMENTATION; GASTROINTESTINAL TRACT; GERMFREE ANIMAL; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; LYMPHOID TISSUE; MICROBIOLOGY; MICROFLORA; MOLECULAR MIMICRY; MOUSE; PHYSIOLOGY; SYMBIOSIS; THIAMINE DEFICIENCY; THYROIDITIS, AUTOIMMUNE;

ANIMALS; BACTERIAL TRANSLOCATION; FERMENTATION; GASTROINTESTINAL TRACT; GERM-FREE LIFE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LYMPHOID TISSUE; MICE; MICROBIOTA; MOLECULAR MIMICRY; PROBIOTICS; SYMBIOSIS; THIAMINE DEFICIENCY; THYROIDITIS, AUTOIMMUNE;

EID: 84962266509     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Bellavia M, Tomasello G, Romeo M, et al. From Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: working hypothesis. Med Microbiol Immunol 2013; 202:393-406.
2. Tralongo P, Tomasello G, Sinagra E, et al. The role of butyric acid as a protective agent against infiammatory bowel disease. Euromediterranean Biomed J 2014; 9(4):24-35.
3. Franchi L. Role of inflammasomes in salmonella infection. Front Microbiol 2011; 2:8.
4. Ogawa H, Fukushima K, Sasaki I, Matsuno S. Identification of genes involved in mucosal defense and inflammation associated with normal enteric bacteria. Am J Physiol Gastrointest Liver Physiol 2000; 279(3):492-9.
5. Abbas A, Lichtman A, Pilla S. Cellular and Molecular Immunology, Eighth Edition, ELSEVIER 2012.
6. Wen Z, Fiocchi C. Inflammatory bowel disease: Autoimmune or immune-mediated pathogenesis? Clin Dev Immunol 2004; 11(3-4):195-204.
7. Björkstén B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001; 108(4):516-20.
8. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411(6837):599-603.
9. Ogura Y, Bonen DK, Inohara N, et al. A frame shift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411(6837):603-6.
10. Mori K, Nakagawa Y, Ozaki H. Does the gut microbiota trigger Hashimoto's thyroiditis? Discov Med 2012; 14(78):321-6.
11. Geraci A, Tomasello G, Termine S, Damiani P, Alongi G, Sanfilippo A, D'Arienzo M. Arthritis associated with ulcerative colitis: our experience in Palermo. Libyan J Med 2009; 4(3):94.
12. Shivashankar R, Loftus EV Jr, Tremaine WJ, Harmsen WS, Zinsmeister AR, Matteson EL. Incidence of Spondyloarthropathy in patients with ulcerative colitis: A population-based study. J Rheumatol 2013; 40(7):1153-7.
13. Calvo P, Pablo L. Managing IBD outside the gut: ocular manifestations. Dig Dis 2013; 31(2):229-32.
14. Weizman AV, Huang B, Targan S, et al. Pyoderma gangrenosum among patients with inflammatory bowel disease: A descriptive cohort study. J Cutan Med Surg 2014; 18(5):361.
15. Alkhateeb H, Said S, Cooper CJ, et al. Myopericarditis as a complication of nonspecific colitis. Am J Case Rep 2014; 15:82-4.
16. Lankarani KB, Sivandzadeh GR, Hassanpour S. Oral manifestation in inflammatory bowel disease: A review. World J Gastroenterol 2013; 19(46):8571-9.
17. Nabokina SM, Inoue K, Subramanian VS, Valle JE, Yuasa H, Said HM. Molecular identification and functional characterization of the human colonic thiamine pyrophosphate transporter. J Biol Chem 2014.
18. Costantini A, Pala MI. Thiamine and fatigue in inflammatory bowel diseases: An open-label pilot study. J Altern Complement Med 2013; 19(8):704-8.
19. Costantini A, Pala MI. Thiamine and Hashimoto's thyroiditis: A report of three cases. J Altern Complement Med 2014; 20(3):208-11.
20. Modebe O. Autoimmune thyroid disease with ulcerative colitis. Postgrad Med J 1986; 62(728):475-6.
21. Marino Gammazza A, Rizzo M, Citarrella R, et al. Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis. Cell Stress Chaperones 2014; 19(3):343-53.
22. Rodolico V, Tomasello G, Zerilli M, et al. Hsp60 and Hsp10 increase in colon mucosa of Crohn's disease and ulcerative colitis. Cell Stress Chaperones 2010; 15(6):877-84.
23. Füst G, Uray K, Bene L, Hudecz F, Karádi I, Prohászka Z. Comparison of epitope specificity of anti-heat shock protein 60/65 IgG type antibodies in the sera of healthy subjects, patients with coronary heart disease and inflammatory bowel disease. Cell Stress Chaperones 2012; 17(2):215-27.
24. Dr. Thomas Gilmore, Biology Department, Boston University. NF-kB Transcription Factors: http://www.bu.edu/nf-kb/.
25. Lührs H, Gerke T, Müller JG, Melcher R, Schauber J, Boxberge F, Scheppach W, Menzel T. Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol 2002; 37(4):458-66.
26. Round JL, O'Connell RM, Mazmanian SK. Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmunol 2010; 34(3):220-25.
27. Foligne B, Zoumpopoulou G, Dewulf J, Younes AB, Chareyre F, Sirad J-C, Pot B, Grangette C. A key role of dendritic cells in probiotic functionality PLoS One 2007; 2(3):e313.
28. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci 2008; 105(43):16731-36.
29. Gill HS, Rutherfurd KJ, Prasad J, Gopal PK. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis(HN019). Br J Nutr 2000; 83(2):167-76.
30. Schmidt EGW, Cleasson MH, Jensen SS, Ravn P, Kristensen NN. Antigen-presenting cells exposed to Lactobacillus acidophilus NCFM, Bifidobacterium bifidum BI-98, and BI-504 reduce regulatory T cell activity. Inflamm Bowel Dis 2010; 16(3):390-400.
31. Mileti E, Matteoli G, Iliev ID, Rescingno M. Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One 2009; 4(9):e7056.
32. Zhou JS, Gill HS. Immunostimulatory probiotic Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 do not induce pathological inflammation in mouse model of experimental autoimmune thyroiditis. Int J Food Microbiol 2005; 103(1):97-104.